(Press-News.org) New York, NY (April 17, 2023) — Tisch Cancer Center scientists have developed unique models of the deadliest blood cancer, acute myeloid leukemia (AML), creating a transformative resource to study this cancer and eventually its drug response and drug resistance. The models were described in a late-breaking abstract at the annual meeting of the American Association of Cancer Research and simultaneously published in Blood Cancer Discovery, a journal of the American Association for Cancer Research.
These are the first powerful models that are nearly identical to AML found in patients. The researchers said these models represent the disease accurately in genetic composition and in disease characteristics found in laboratory cell cultures, animal models, and patients.
AML is a fast-growing cancer with only a 29 percent survival rate. It has often already spread widely in the bone marrow and blood by the time it’s first discovered in a patient, so being able to study the cancer, its progression, and its response to drugs in accurate and viable cell lines is crucial.
“We show that these models are nearly identical to the leukemias of the patients that they came from and thus are faithful models for acute myeloid leukemia,” said senior author Eirini Papapetrou, MD, PhD, Professor of Oncological Sciences, and Medicine (Hematology and Medical Oncology), at The Tisch Cancer Institute, part of the Tisch Cancer Center, and Director of the Center for Advancement of Blood Cancer Therapies (CABCT) at the Institute for Regenerative Medicine at the Icahn School of Medicine at Mount Sinai. “Animal models do not provide accurate genetic models of AML, AML cells from the bone marrow or blood survive poorly outside of the body, and AML cell lines carry many additional genetic and karyotypic abnormalities that make them distinct from primary tumors. Our new models are groundbreaking tools that can uniquely empower leukemia research.”
To create these models, researchers used genetic reprogramming technology to convert blood or bone marrow cells from 15 patients representing all major genetic groups of AML to a particular type of stem cells (called induced pluripotent stem cells) that can mimic different stages of disease progression, from a healthy state to pre-malignancy and finally full-blown leukemia. Importantly, the leukemia cells derived from these lines can be transplanted into animal models and create a disease remarkably similar to that seen in the patients.
Many of these lines have been distributed to other researchers, who, along with Dr. Papapetrou and her colleagues, will pursue a number of new studies into leukemia pathogenesis and drug responses. A commentary on the significance of Dr. Papapetrou’s journal article in Blood Cancer Discovery explains how the study advances the field, both practically and conceptually.
"The large panel of genetically defined iPSC clones . . . are versatile disease models and important resources for the community," the commentary, written by Sergei Doulatov, PhD, Associate Professor of Hematology at the University of Washington, says. "This study dispels the notion that leukemias are difficult or impossible to reprogram."
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
END
Scientists create powerful, most-accurate tools to research deadliest blood cancer, study says
Journal commentary: these are “versatile disease models and important resources for the community”
2023-04-17
ELSE PRESS RELEASES FROM THIS DATE:
EMBARGOED: Two brain networks are activated while reading, study finds
2023-04-17
When a person reads a sentence, two distinct networks in the brain are activated, working together to integrate the meanings of the individual words to obtain more complex, higher-order meaning, according to a study at UTHealth Houston.
The study, led by Oscar Woolnough, PhD, postdoctoral research fellow in the Vivian L. Smith Department of Neurosurgery with McGovern Medical School at UTHealth Houston, and Nitin Tandon, MD, professor and chair ad interim of the department in the medical school, was published ...
The surprising science behind long-distance bird migration
2023-04-17
AMHERST, Mass. – A team of scientists led by researchers at the University of Massachusetts Amherst has recently made a surprising discovery, with the help of a wind tunnel and a flock of birds. Songbirds, many of which make twice-yearly, non-stop flights of more than 1,000 miles to get from breeding range to wintering range, fuel themselves by burning lots of fat and a surprising amount of the protein making up lean body mass, including muscle, early in the flight. This flips the conventional wisdom ...
Fossils reveal the long-term relationship between feathered dinosaurs and feather-feeding beetles
2023-04-17
New fossils in amber have revealed that beetles fed on the feathers of dinosaurs about 105 million years ago, showing a symbiotic relationship of one-sided or mutual benefit, according to an article published in Proceedings of the National Academy of Sciences of the United States of America today*.
The main amber fragments studied, from the Spanish locality of San Just (Teruel), contain larval moults of small beetle larvae tightly surrounded by portions of downy feathers. The feathers belonged to an unknown theropod dinosaur, either avian (a term referring ...
Sea-level rise in southwest Greenland as a contributor to Viking abandonment
2023-04-17
Vikings occupied Greenland from roughly 985 to 1450, farming and building communities before abandoning their settlements and mysteriously vanishing. Why they disappeared has long been a puzzle, but a new paper from the Department of Earth and Planetary Sciences (EPS) determines that one factor – rising sea level – likely played a major role.
“There are many theories as to what exactly happened” to drive the Vikings from their settlements in Greenland, said Marisa J. Borreggine, lead author of the “Sea-Level ...
SWOG researchers report results in rare gynecologic cancers from DART immunotherapy trial
2023-04-17
Results from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of patients with rare cancers, are being reported for five cohorts of patients who had rare gynecologic cancers.
In three of those five cohorts – the cohorts for clear cell ovarian cancer; small cell ovarian carcinoma, hypercalcemic type; and non-epithelial ovarian cancer – some patients have shown durable responses to the immunotherapy, including several patients whose complete remissions have now lasted more than three years.
The findings will be presented in three abstracts at the 2023 ...
Can you describe a sensation without feeling it first?
2023-04-17
Blind or colorblind people can describe colors and use expressions like “green with envy” or “feeling blue.” A hearing-impaired person can also say those same vibrant hues are “loud.” But many linguists and cognitive neuroscientists have assumed that somatosensation—touch, pain, pressure, temperature, and proprioception, or the sense of where your body is oriented in space—is fundamental for understanding metaphors that have to do with tactile sensations. Understanding expressions like “she is having a tough time” or “that class was hard,” it was believed, requires previous experience with those sensations to extend ...
p21 facilitates chronic lung inflammation via epithelial and endothelial cells
2023-04-17
“Our results implicate p21 as a critical regulator of chronic bronchitis and a driver of chronic airway inflammation and lung destruction.”
BUFFALO, NY- April 17, 2023 – A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 7, entitled, “p21 facilitates chronic lung inflammation via epithelial and endothelial cells.”
Cellular senescence is a stable state of cell cycle arrest that regulates tissue ...
International clinical trial conducts head-to-head comparison of open versus minimally invasive surgery for early-stage cervical cancer
2023-04-17
COLUMBUS, Ohio – Gynecologic surgeons with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) are leading an international clinical trial to determine whether minimally invasive surgery robotic surgery is better or worse than open surgery when performing a radical hysterectomy to treat cervical cancer.
Although minimally invasive and robotic-assisted surgery techniques have become the standard approach for many surgeries, in gynecologic cancer open surgery – which involves one ...
nPOD honors Estefania Quesada Masachs for type 1 diabetes discoveries
2023-04-17
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) Instructor Estefania Quesada Masachs, M.D., Ph.D., has won the 2023 Young Investigator of the Year Award from the Network for Pancreatic Organ donors with Diabetes (nPOD). This prestigious award recognizes Quesada Masachs' groundbreaking research in type 1 diabetes.
Quesada Masachs says she was "happily surprised" to receive the award from nPOD at their 2023 conference. The organization provides pancreatic tissue samples to researchers, opening the door for in-depth research into type 1 diabetes, an autoimmune disease where the body's own immune ...
Cancer prevention with rapamycin
2023-04-17
“[...] long-term treatment with rapamycin slows down aging, a major risk factor for cancer [...]”
BUFFALO, NY- April 17, 2023 – A new research perspective was published in Oncotarget's Volume 14 on April 14, 2023, entitled, “Cancer prevention with rapamycin.”
The mTOR (Target of Rapamycin) pathway is involved in both cancer and aging. Furthermore, common cancers are age-related diseases, and their incidence increases exponentially with age. In his new research perspective, Mikhail V. Blagosklonny, M.D., Ph.D., from Roswell Park Comprehensive Cancer Center discusses rapamycin and other rapalogs and their ...
LAST 30 PRESS RELEASES:
People with sensitive personalities more likely to experience mental health problems
Want to improve early detection of diabetes? Look in the same households as those with abnormal blood sugar
Unveiling the gut-heart connection: The role of microbiota in heart failure
Breakthrough insights into tumor angiogenesis and endothelial cell origins
Unlocking the power of mitochondrial biogenesis to combat acute kidney injury
MIT study sheds light on graphite’s lifespan in nuclear reactors
The role of fucosylation in digestive diseases and cancer
Meet Allie, the AI-powered chess bot trained on data from 91 million games
Students’ image tool offers sharper signs, earlier detection in the lab or from space
UBC Okanagan study suggests fasting effects on the body are not the same for everyone
Children’s Hospital of Philadelphia and Children’s Hospital Colorado researchers conduct first prospective study of pediatric EoE patients and disease progression
Harnessing VR to prevent substance use relapse
The 8,000-year history recorded in Great Salt Lake sediments
To craft early tools, ancient human relatives transported stones over long distances 600,000 years earlier than previously thought
Human embryo implantation recorded in real time for the first time
70 years of data show adaptation reducing Europe’s flood losses
Recapitulating egg and sperm development in the dish
Study reveals benefits of traditional Himalayan crops
Scientist uncover hidden immune “hubs” that drive joint damage in rheumatoid arthritis
Congress of Neurological Surgeons releases first guidelines on the care of patients with functioning pituitary adenomas
New discovery could lower heart attack and stroke risk for people with type 2 diabetes
Tumor electrophysiology in precision tumor therapy
AI revolution in medicine: how large language models are transforming drug development
Hidden contamination in DNA extraction kits threatens accuracy of global zoonotic surveillance
Slicing and dictionaries: a new approach to medical big data
60 percent of the world’s land area is in a precarious state
Thousands of kids in mental health crisis are stuck for days in hospital emergency rooms, study finds
Prices and affordability of essential medicines in 72 low-, middle-, and high-income markets
Space mice babies
FastUKB: A revolutionary tool for simplifying UK Biobank data analysis
[Press-News.org] Scientists create powerful, most-accurate tools to research deadliest blood cancer, study saysJournal commentary: these are “versatile disease models and important resources for the community”